NBSE · Categories · Form 3

NBSE - SEC Form 3 initial insider statements

NeuBase Therapeutics Inc. (NBSE) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for NBSE

• 1002d
  SEC Form 3: New insider Symetryx Corp claimed ownership of 190,481 shares (Amendment)

  3/A - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
• 1013d
  SEC Form 3: New insider Symetryx Corp claimed ownership of 618,925 shares

  3 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
• 1612d
  SEC Form 3 filed by new insider Branning Todd P.

  3 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
• 1617d
  SEC Form 3 filed by new insider Ende Eric J

  3 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
• 1842d
  SEC Form 3 filed by NeuBase Therapeutics, Inc.

  3 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
• 1842d
  SEC Form 3 filed by NeuBase Therapeutics, Inc.

  3 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
• 1854d
  SEC Form 3 filed by McDougall Gerald J

  3 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)

Other NBSE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends